IGF1 and acromegaly: Few studies have analyzed the spectrum of available treatments for managing GH and IGF-1 levels in acromegaly, focusing on the efficacy, safety, and patient satisfaction of treatment with octreotide capsules (Mycapssa®) across multiple clinical trials and open-label extensions of these trials.